Compare · ALC vs LUCY
ALC vs LUCY
Side-by-side comparison of Alcon Inc. (ALC) and Innovative Eyewear Inc. (LUCY): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ALC and LUCY operate in Ophthalmic Goods (Health Care), so they compete in similar markets.
- ALC is the larger of the two at $37.03B, about 5505.8x LUCY ($6.7M).
- LUCY has been more active in the news (8 items in the past 4 weeks vs 2 for ALC).
- ALC has more recent analyst coverage (25 ratings vs 0 for LUCY).
- Company
- Alcon Inc.
- Innovative Eyewear Inc.
- Price
- -
- -
- Market cap
- $37.03B
- $6.7M
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Ophthalmic Goods
- Ophthalmic Goods
- Exchange
- NYSE
- NASDAQ
- IPO
- 2019
- 2022
- News (4w)
- 2
- 8
- Recent ratings
- 25
- 0
Alcon Inc.
Alcon, Inc., an eye care company, researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for use in surgical procedures. Its cataract products include centurion vision system, LenSx femtosecond laser, LuxOR surgical ophthalmic microscope, NGENUITY 3D visualization system, and ORA system for intra-operative measurements; custom pak surgical procedure packs; vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, and grieshaber and MIVS instruments, as well as scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; refractive surgery products, including WaveLight lasers and Contoura Vision used for LASIK treatment; and EX-PRESS glaucoma filtration device; and implantables products, including AcrySof IQ IOLs products include monofocal IOLs and advanced technology IOLs under PanOptix and ReSTOR brands for the correction of presbyopia and astigmatism at the time of cataract surgery. Its Vision Care segment provides daily disposable, reusable, and color-enhancing contact lenses; ocular health products, including devices and over-the-counter products for dry eye, over-the-counter products for contact lens care, and ocular allergies; and ocular vitamins and redness relievers under the TOTAL, PRECISION, DAILIES AquaComfort PLUS, Air Optix, Opti-Free, Clear Care, Tears Naturale, Genteal, ICAPS, and Vitalux brands. The company was formerly known as Alcon Universal S.A. and changed the name to Alcon, Inc. in December 2001. Alcon, Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.
Latest ALC
- SEC Form 6-K filed by Alcon Inc.
- Innovation and Product Launch Momentum Drive Alcon’s Third-Quarter 2026 Growth
- Alcon Acquires Neurotech and ENCELTO, the Only FDA-Approved Treatment for MacTel Type 2
- FDA Approves Alcon’s BRYTLY Redness Reliever Eye Drops for Up to 12 Hours of Whiter, Brighter-Looking Eyes
- Barclays initiated coverage on Alcon with a new price target
- Introducing Systane® PRO PRESERVATIVE-FREE: Alcon’s Longest Lasting, Triple-Action Formula for up to 12 Hours of Dry Eye Symptom Relief
- Alcon Launches UNITY M, a Premium Ophthalmic Microscope Delivering Precise Control
- Alcon Prices EUR 500 Million Senior Notes Offering
- Alcon downgraded by BNP Paribas Exane with a new price target
- SEC Form 6-K filed by Alcon Inc.
Latest LUCY
- Amendment: SEC Form SCHEDULE 13G/A filed by Innovative Eyewear Inc.
- SEC Form 10-Q filed by Innovative Eyewear Inc.
- Innovative Eyewear Reports Third-Quarter 2026 Results
- Chief Financial Officer Gayle Oswald was granted 60,000 shares, increasing direct ownership by 303% to 79,798 units (SEC Form 4)
- Chief AI & Growth Officer Dabrowski Konrad was granted 50,000 shares, increasing direct ownership by 122% to 90,977 units (SEC Form 4)
- Chief Operating Officer Abondano Joaquin was granted 90,000 shares, increasing direct ownership by 360% to 115,012 units (SEC Form 4)
- Chief Executive Officer Gross Harrison R. was granted 100,000 shares, increasing direct ownership by 284% to 135,195 units (SEC Form 4)
- Chief Technology Officer Cohen David Eric was granted 60,000 shares, increasing direct ownership by 254% to 83,622 units (SEC Form 4)
- Innovative Eyewear, Inc. Receives Time Magazine's Best Inventions of 2026 Award
- SEC Form 8-K filed by Innovative Eyewear Inc.